Sensus Healthcare director Eric Sachetta buys $112,904 in stock
Eric Sachetta, a director at Sensus Healthcare (SRTS), bought 34,697 shares for $112,904 at $3.254 per share. He now holds 209,310 shares directly and 2,093 indirectly. SRTS stock rose 16% in the past week but faces profitability challenges. Q2 2026 results missed expectations, with a loss of $0.53 per share and revenue of $2.3M, down 68.5% YoY. Management cited financing delays but expects stronger H2 2026 performance.
How this was made
The 30-second read
Why it matters
The insider purchase occurs amid a weak earnings quarter, providing limited bullish impetus.
Market read
Micro‑cap insider activity with modest relevance; unlikely to affect broader market.
What to watch
Recent Q2 loss and revenue miss may outweigh any positive signal from the insider buy.
Background
Sensus Healthcare reported a Q2 2026 loss of $0.53 per share on $2.3 M revenue, missing expectations.
Ticker impact
Director Eric Sachetta bought 34,697 shares at $3.254, valued at $112,904.
Minor upside potential, unlikely to move price materially.
Form 4 filing is primary disclosure; amount is small relative to market cap.
Market effects
Limited; reflects insider activity in the medical‑device sector.
None beyond the microcap's niche market.
Minimal.
Counterpoint
The purchase could be a routine portfolio rebalancing rather than a confidence signal.
Key entities
- CompanySensus Healthcare Inc.
Medical‑device maker listed on Nasdaq (SRTS).
- IndividualEric Sachetta
Director of Sensus Healthcare.
